• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别隐藏人群:不再与服务机构有联系的 former Intravenous Drug Users(原文此处有误,应为Former Intravenous Drug Users,即 former 静脉注射吸毒者)。“问问朋友”。

Identifying the Hidden Population: Former Intravenous Drug Users Who Are No Longer in Contact with Services. "Ask a Friend".

作者信息

Donaldson Sarah R, Radley Andrew, Dillon John F

机构信息

School of Medicine, University of Dundee, Dundee DD1 9SY, UK.

Directorate of Public Health, NHS Tayside, Dundee DD3 8EA, UK.

出版信息

Diagnostics (Basel). 2021 Jan 25;11(2):170. doi: 10.3390/diagnostics11020170.

DOI:10.3390/diagnostics11020170
PMID:33504077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7911884/
Abstract

People who, after a period of drug use, have changed their lifestyle and left substance use behind them are a hidden population within our communities. Lack of contact with drug services may mean that they are not tested for hepatitis C (HCV) infection through service-led initiatives and, therefore, may be exposed to the chronic morbidity and risk of death inherent with a legacy of HCV infection. This study utilized respondent-driven sampling (RDS) in a novel fashion to find those at historical risk of HCV. The social networks of people with a history of drug use were mapped, and individuals not currently in contact with services were invited to come forward for testing by members of their social network. The study used a reference group to inform study methodology and communication methods to reach out to this hidden population. One hundred and nine individuals received dry blood spot tests for HCV, 17.4% were antibody positive. Fifty one individuals met the inclusion criteria for this study. One hundred and twenty three invite-to-test coupons were issued; however, only one wave of recruitment consisting of one participant resulted from this method. Using RDS in historical social networks was not effective in this study and did not reach this hidden population and increase testing for HCV. This study is registered with clinicaltrials.gov (Ref NCT03697135).

摘要

在经历一段时间的药物使用后,改变了生活方式并戒除毒品的人群是我们社区中的一个隐蔽群体。由于缺乏与毒品服务机构的接触,这可能意味着他们没有通过服务主导的举措接受丙型肝炎(HCV)感染检测,因此,可能会面临HCV感染遗留下来的慢性发病风险和死亡风险。本研究以一种新颖的方式利用应答驱动抽样(RDS)来寻找有HCV历史风险的人群。绘制了有吸毒史人群的社交网络,并邀请目前未与服务机构接触的个人由其社交网络成员前来接受检测。该研究使用了一个参考组来为研究方法和沟通方式提供信息,以接触到这个隐蔽群体。109人接受了HCV干血斑检测,17.4%的人抗体呈阳性。51人符合本研究的纳入标准。发放了123张邀请检测券;然而,这种方法仅产生了一波由一名参与者组成的招募。在本研究中,在历史社交网络中使用RDS并不有效,未能接触到这个隐蔽群体,也未增加HCV检测。本研究已在clinicaltrials.gov注册(参考编号NCT03697135)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/7911884/4d46940d9094/diagnostics-11-00170-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/7911884/94608c974ab3/diagnostics-11-00170-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/7911884/4d46940d9094/diagnostics-11-00170-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/7911884/94608c974ab3/diagnostics-11-00170-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ff0/7911884/4d46940d9094/diagnostics-11-00170-g002.jpg

相似文献

1
Identifying the Hidden Population: Former Intravenous Drug Users Who Are No Longer in Contact with Services. "Ask a Friend".识别隐藏人群:不再与服务机构有联系的 former Intravenous Drug Users(原文此处有误,应为Former Intravenous Drug Users,即 former 静脉注射吸毒者)。“问问朋友”。
Diagnostics (Basel). 2021 Jan 25;11(2):170. doi: 10.3390/diagnostics11020170.
2
Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.丙型肝炎病毒在注射吸毒人群中的生物行为学调查——对反应驱动抽样理论假设敏感性的系统评价。
Harm Reduct J. 2017 Jul 11;14(1):44. doi: 10.1186/s12954-017-0172-z.
3
Respondent-driven sampling and the recruitment of people with small injecting networks.应答驱动抽样法与小型注射网络人群的招募。
AIDS Behav. 2012 May;16(4):890-9. doi: 10.1007/s10461-011-0032-x.
4
Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.印度采用应答者驱动抽样法识别注射吸毒的艾滋病毒和丙型肝炎病毒感染者及男男性行为者:一项基于社区的横断面分析。
PLoS Med. 2017 Nov 28;14(11):e1002460. doi: 10.1371/journal.pmed.1002460. eCollection 2017 Nov.
5
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).注射吸毒者中艾滋病毒和丙型肝炎病毒血清流行率及风险行为的高度变异性:一项在德国八个城市采用应答者驱动抽样的横断面研究(2011 - 2014年)结果
BMC Public Health. 2016 Sep 5;16(1):927. doi: 10.1186/s12889-016-3545-4.
6
Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.格鲁吉亚第比利斯注射吸毒者中的丙型肝炎:预防和治疗的迫切需求
Int J Drug Policy. 2014 Sep;25(5):871-8. doi: 10.1016/j.drugpo.2014.01.007. Epub 2014 Jan 23.
7
A comparison of network sampling designs for a hidden population of drug users: Random walk vs. respondent-driven sampling.针对吸毒者这一隐性群体的网络抽样设计比较:随机游走抽样与应答驱动抽样。
Soc Sci Res. 2017 Feb;62:350-361. doi: 10.1016/j.ssresearch.2016.08.016. Epub 2016 Aug 27.
8
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.注射吸毒者中艾滋病毒、乙肝表面抗原和丙型肝炎抗体阳性的高流行率:莫桑比克两个城市地区首次采用应答者驱动抽样进行生物行为调查的结果。
BMC Infect Dis. 2019 Dec 2;19(1):1022. doi: 10.1186/s12879-019-4655-2.
9
Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.克罗地亚两个城市注射毒品者中抗丙型肝炎阳性及使用减少伤害服务的相关因素。
Drug Alcohol Depend. 2017 Feb 1;171:132-139. doi: 10.1016/j.drugalcdep.2016.11.028. Epub 2016 Dec 7.
10
Using Network Sampling and Recruitment Data to Understand Social Structures Related to Community Health in a Population of People Who Inject Drugs in Rural Puerto Rico.利用网络抽样和招募数据来了解波多黎各农村地区注射吸毒人群中与社区健康相关的社会结构。
P R Health Sci J. 2017 Jun;36(2):77-83.

引用本文的文献

1
Viral hepatitis in 2021: The challenges remaining and how we should tackle them.2021 年的病毒性肝炎:尚存的挑战与应对策略
World J Gastroenterol. 2022 Jan 7;28(1):76-95. doi: 10.3748/wjg.v28.i1.76.

本文引用的文献

1
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.药师主导与常规提供的抗病毒治疗在接受阿片类药物替代治疗的丙型肝炎病毒患者中的临床效果:一项实用的、集群随机试验。
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):809-818. doi: 10.1016/S2468-1253(20)30120-5. Epub 2020 Jun 8.
2
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).评估丙型肝炎直接抗病毒治疗作为对注射毒品者的预防措施所产生的人群影响(EPIToPe)——一项自然实验(方案)
BMJ Open. 2019 Sep 24;9(9):e029538. doi: 10.1136/bmjopen-2019-029538.
3
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study.在注射设备提供点进行的随机对照试验,比较不同丙型肝炎治疗方案在注射毒品人群中的疗效:直接观察治疗与每两周收集一次的 HCV 治疗 ADVANCE HCV 方案研究。
BMJ Open. 2019 Aug 8;9(8):e029516. doi: 10.1136/bmjopen-2019-029516.
4
High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme.在社区针具交换项目中治疗丙型肝炎的吸毒者中,高反应率和再感染率。
J Viral Hepat. 2019 May;26(5):519-528. doi: 10.1111/jvh.13035. Epub 2018 Dec 12.
5
Dry blood spot testing for hepatitis C in people who injected drugs: reaching the populations other tests cannot reach.对注射吸毒者进行丙型肝炎干血斑检测:覆盖其他检测方法无法触及的人群。
Frontline Gastroenterol. 2013 Oct;4(4):255-262. doi: 10.1136/flgastro-2013-100308. Epub 2013 May 11.
6
DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.DOT-C:一项在社区药房接受阿片类药物替代治疗的人群中评估直接观察抗 HCV 治疗的整群随机可行性试验。
Int J Drug Policy. 2017 Sep;47:126-136. doi: 10.1016/j.drugpo.2017.05.042. Epub 2017 Jun 21.
7
Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature.与丙型肝炎病毒共存:定性文献的系统评价和叙述性综合。
Can J Gastroenterol Hepatol. 2017;2017:3268650. doi: 10.1155/2017/3268650. Epub 2017 Apr 26.
8
Social identity, social networks and recovery capital in emerging adulthood: A pilot study.新兴成年期的社会认同、社会网络与恢复资本:一项初步研究。
Subst Abuse Treat Prev Policy. 2015 Nov 11;10:45. doi: 10.1186/s13011-015-0041-2.
9
Approaches to Recruiting 'Hard-To-Reach' Populations into Re-search: A Review of the Literature.将“难以触及”人群纳入研究的招募方法:文献综述
Health Promot Perspect. 2011 Dec 20;1(2):86-94. doi: 10.5681/hpp.2011.009. eCollection 2011.
10
Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.从社会角度理解丙型肝炎病毒治疗的障碍和污名化。
Clin Infect Dis. 2013 Aug;57 Suppl 2:S51-5. doi: 10.1093/cid/cit263.